It may prove useful in some individuals but it remains an extrapolated and nuanced position, not yet one settled with robust evidence
doi: 10.3389/fbioe.2025.1729166 Received 21 October 2025 Revised 01 December 2025 Accepted 17 December 2025 Published 15 January 2026 Volume 13 - 2025 Edited by Ling Wang, Dalian Medical University, China Reviewed by Nicola Alessio, University of Campania Luigi Vanvitelli, Italy Yesuf Adem Siraj, Bahir Dar University, Ethiopia Updates Copyright 2026 Hu, Li, Hu, Shan, Tang, Jiang, Yi, Chen, Jin, Wang and Wang
Related Medications Flonase Nasal Spray (fluticasone propionate) Nasacort Allergy 24 Hour (triamcinolone acetonide) Nasonex Nasal Spray (mometasone) Claritin (loratadine) Zyrtec (cetirizine) Xyzal (levocetirizine) Clarinex (desloratadine) Sources Misaka S, et al
"Assessing oxidative pathway genes as risk factors for bipolar disorder"